Report Categories
View AllRecent Articles
View All
Lam Research Corporation LRCX Q3 FY2026 Earnings Beat Drives Analyst Price Target Upgrade AI Semiconductor Demand Supports Bullish Outlook
ERNAW Ernexa to share quarterly earnings context and updated clinical pipeline progress with investors this month
GrowGeneration GRWG Stock Downside Risk Overview Q4 2025 EPS Misses Views
Qualcomm Inc QCOM Cramers Parabolic ARM Holdings Commentary Highlights Undervalued Semiconductor Peer Upside
Jim Cramer Suggests Trimming Positions in Volatile AI Chipmaker
Understanding Japans Economic Landscape Through Cultural Nuances
Cisco Announces Nearly 4000 Job Cuts Amid AIDriven Revenue Growth
Hezbollah FibreOptic Drone Tactics Geopolitical Risk and Market Implications
AZZ AZZ Q1 2026 Beat Revenue NA EPS Exceeds by Significant
IN8bio INAB Q1 2026 Earnings Beat Revenue NA EPS 026
Charles River CRL Stock Down 445 Support Test at 14444 20260515
ePlus inc PLUS Q1 2026 Earnings 145 EPS Surges Past 103 Estimates
Sharps STSSW Stock Down 180 Support Test at 004 20260520
Expand Energy EXE Holds Above Key Support Despite Slight Decline
Nvidia Acknowledges Largely Conceding Chinas AI Chip Market to Huawei
TNDM Q1 2026 Earnings Narrower Loss Beats Estimates Shares Rally
AIDriven Layoffs Stock Market Boost or Uncomfortable Reality
UK and Gulf States Sign Historic Trade Deal Poised to Boost Economy by Billions
Movado Group Inc Releases Quarterly Earnings Report Key Highlights from Latest 10Q Filing
Waymo Temporarily Halts Robotaxi Operations in Five US Cities Following FloodRelated Incidents
NYT Pips Puzzle Hints and Answers Released Potential Impact on Digital Engagement
Traders Now Eye Potential Fed Rate Hike as Inflation Surge Fuels Policy Shift
PENN Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
ASRT Q1 2026 Earnings Significant EPS Miss Amid Revenue Disclosure Absence
EFOI Q4 2024 Earnings Narrowed Loss Amid Continued Strategic Restructuring
EPC Q1 2026 Earnings Margin Pressures Weigh on EPS but Investor Confidence Holds
CRVS Q1 2026 Earnings EPS Slightly Misses Estimates Amid Continued Clinical Development